Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14916698 | Publishing Date : 20-Nov-2019 | No. of pages : 93
Detailed TOC of Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Crizotinib
1.4.3 Alectinib
1.4.4 Ceritinib
1.4.5 Brigatinib
1.4.6 Other
1.5 Market by Application
1.5.1 Global ALK Positive Lung Cancer Treatment Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 ALK Positive Lung Cancer Treatment Market Size
2.2 ALK Positive Lung Cancer Treatment Growth Trends by Regions
2.2.1 ALK Positive Lung Cancer Treatment Market Size by Regions (2019-2025)
2.2.2 ALK Positive Lung Cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 ALK Positive Lung Cancer Treatment Market Size by by Players
3.1.1 Global ALK Positive Lung Cancer Treatment Revenue by by Players (2014-2019)
3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served
3.3 Key Players ALK Positive Lung Cancer Treatment Product/Solution/Service
3.4 Date of Enter into ALK Positive Lung Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global ALK Positive Lung Cancer Treatment Market Size by Type (2014-2019)
4.2 Global ALK Positive Lung Cancer Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America ALK Positive Lung Cancer Treatment Market Size (2014-2019)
5.2 ALK Positive Lung Cancer Treatment Key Players in North America
5.3 North America ALK Positive Lung Cancer Treatment Market Size by Type
5.4 North America ALK Positive Lung Cancer Treatment Market Size by Application
6 Europe
6.1 Europe ALK Positive Lung Cancer Treatment Market Size (2014-2019)
6.2 ALK Positive Lung Cancer Treatment Key Players in Europe
6.3 Europe ALK Positive Lung Cancer Treatment Market Size by Type
6.4 Europe ALK Positive Lung Cancer Treatment Market Size by Application
7 China
7.1 China ALK Positive Lung Cancer Treatment Market Size (2014-2019)
7.2 ALK Positive Lung Cancer Treatment Key Players in China
7.3 China ALK Positive Lung Cancer Treatment Market Size by Type
7.4 China ALK Positive Lung Cancer Treatment Market Size by Application
8 Japan
8.1 Japan ALK Positive Lung Cancer Treatment Market Size (2014-2019)
8.2 ALK Positive Lung Cancer Treatment Key Players in Japan
8.3 Japan ALK Positive Lung Cancer Treatment Market Size by Type
8.4 Japan ALK Positive Lung Cancer Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia ALK Positive Lung Cancer Treatment Market Size (2014-2019)
9.2 ALK Positive Lung Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Type
9.4 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Application
10 India
10.1 India ALK Positive Lung Cancer Treatment Market Size (2014-2019)
10.2 ALK Positive Lung Cancer Treatment Key Players in India
10.3 India ALK Positive Lung Cancer Treatment Market Size by Type
10.4 India ALK Positive Lung Cancer Treatment Market Size by Application
11 Central & South America
11.1 Central & South America ALK Positive Lung Cancer Treatment Market Size (2014-2019)
11.2 ALK Positive Lung Cancer Treatment Key Players in Central & South America
11.3 Central & South America ALK Positive Lung Cancer Treatment Market Size by Type
11.4 Central & South America ALK Positive Lung Cancer Treatment Market Size by Application
12 International Players Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 ALK Positive Lung Cancer Treatment Introduction
12.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019))
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 ALK Positive Lung Cancer Treatment Introduction
12.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 ALK Positive Lung Cancer Treatment Introduction
12.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 TP Therapeutics
12.4.1 TP Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 ALK Positive Lung Cancer Treatment Introduction
12.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019)
12.4.5 TP Therapeutics Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 ALK Positive Lung Cancer Treatment Introduction
12.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Eli Lilly and Company
12.6.1 Eli Lilly and Company Company Details
12.6.2 Company Description and Business Overview
12.6.3 ALK Positive Lung Cancer Treatment Introduction
12.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019)
12.6.5 Eli Lilly and Company Recent Development
12.7 Takeda
12.7.1 Takeda Company Details
12.7.2 Company Description and Business Overview
12.7.3 ALK Positive Lung Cancer Treatment Introduction
12.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019)
12.7.5 Takeda Recent Development
12.8 Beacon Pharma
12.8.1 Beacon Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 ALK Positive Lung Cancer Treatment Introduction
12.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019)
12.8.5 Beacon Pharma Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable ALK Positive Lung Cancer Treatment Key Market Segments
Table Key Players ALK Positive Lung Cancer Treatment Covered
Table Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Crizotinib Figures
Table Key Players of Crizotinib
Figuer Alectinib Figures
Table Key Players of Alectinib
Figuer Ceritinib Figures
Table Key Players of Ceritinib
Figuer Brigatinib Figures
Table Key Players of Brigatinib
Figuer Other Figures
Table Key Players of Other
Table Global ALK Positive Lung Cancer Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global ALK Positive Lung Cancer Treatment Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure ALK Positive Lung Cancer Treatment Report Years Considered
Figure Global ALK Positive Lung Cancer Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global ALK Positive Lung Cancer Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global ALK Positive Lung Cancer Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global ALK Positive Lung Cancer Treatment Market Share by Regions 2014-2019
Figure Global ALK Positive Lung Cancer Treatment Market Share by Regions 2014-2019
Figure Global ALK Positive Lung Cancer Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global ALK Positive Lung Cancer Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global ALK Positive Lung Cancer Treatment Market Share by by Players (2014-2019)
Figure Global ALK Positive Lung Cancer Treatment Market Share by by Players in 2018
Table Global ALK Positive Lung Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players ALK Positive Lung Cancer Treatment Product/Solution/Service
Table Date of Enter into ALK Positive Lung Cancer Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global ALK Positive Lung Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Global ALK Positive Lung Cancer Treatment Market Size Share by Type (2014-2019)
Figure Global ALK Positive Lung Cancer Treatment Market Size Market Share by Type (2014-2019)
Table Global ALK Positive Lung Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Global ALK Positive Lung Cancer Treatment Market Size Share by Application (2014-2019)
Figure Global ALK Positive Lung Cancer Treatment Market Size Market Share by Application (2014-2019)
Figure Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application in 2018
Figure North America ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019)
Table North America ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$)
Table North America ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019
Table North America ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$)
Table North America ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019
Figure Europe ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019)
Table Europe ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019
Table Europe ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019
Figure China ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$)
Table China Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$)
Table China Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019)
Table China ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$)
Table China ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019
Table China ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$)
Table China ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019
Figure Japan ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019)
Table Japan ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019
Table Japan ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019
Figure Southeast Asia ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019)
Table Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019
Table Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019
Figure India ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$)
Table India Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$)
Table India Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019)
Table India ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$)
Table India ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019
Table India ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$)
Table India ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019
Figure Central & South America ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019)
Table Central & South America ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019
Table Central & South America ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019)
Table Novartis Recent Development
Table TP Therapeutics Company Details
Table TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$)
Figure TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019)
Table TP Therapeutics Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Takeda Company Details
Table Takeda Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$)
Figure Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019)
Table Takeda Recent Development
Table Beacon Pharma Company Details
Table Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$)
Figure Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019)
Table Beacon Pharma Recent Development
Table Global ALK Positive Lung Cancer Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global ALK Positive Lung Cancer Treatment Market Size Share by Regions (2019-2025)
Figure Global ALK Positive Lung Cancer Treatment Market Size Share by Regions in 2025
Figure North America ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global ALK Positive Lung Cancer Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global ALK Positive Lung Cancer Treatment Market Size by Product (2019-2025)
Figure Global ALK Positive Lung Cancer Treatment Market Size by Product in 2025
Table Global ALK Positive Lung Cancer Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global ALK Positive Lung Cancer Treatment Market Size by Application (2019-2025)
Figure Global ALK Positive Lung Cancer Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2019-2025
F. Hoffmann-La RochePfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company
Takeda
Beacon Pharma